$INFU
InfuSystem Holdings, Inc Stock $infu

$infu Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-Q Financial Statement

#000143774920010921 Filed on May 15, 2020

Income Statement

Concept	2020 Q1	2019 Q1	2018 Q4
Revenue	$21.55M	$18.19M	$17.56M
YoY Change	18.47%	10.37%	-7.02%
Cost Of Revenue	$8.890M	$7.852M	$7.590M
YoY Change	13.22%	25.71%	17.49%
Gross Profit	$12.66M	$10.34M	$9.973M
YoY Change	22.45%	1.02%	-19.83%
Gross Profit Margin	58.75%	56.84%	56.78%
Selling, General & Admin	$11.27M	$9.734M	$8.610M
YoY Change	15.78%	15.03%	-15.34%
% of Gross Profit	89.0%	94.13%	86.33%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.328M	$1.225M	$1.237M
YoY Change	90.04%	-5.04%	-16.42%
% of Gross Profit	18.38%	11.85%	12.4%
Operating Expenses	$12.63M	$10.76M	$9.847M
YoY Change	17.37%	11.52%	-15.4%
Operating Profit	$33.00K	-$420.0K	$126.0K
YoY Change	-107.86%	-171.43%	-84.25%
Interest Expense	$403.0K	$460.0K	-$439.0K
YoY Change	-12.39%	46.03%	37.19%
% of Operating Profit	1221.21%		-348.41%
Other Income/Expense, Net	-$19.00K	-$21.00K	-$18.00K
YoY Change	-9.52%	90.91%
Pretax Income	-$389.0K	-$901.0K	-$331.0K
YoY Change	-56.83%	-443.89%	-79.69%
Income Tax	$29.00K	$59.00K	-$56.00K
% Of Pretax Income
Net Earnings	-$418.0K	-$960.0K	-$275.0K
YoY Change	-56.46%	-570.59%	-98.47%
Net Earnings / Revenue	-1.94%	-5.28%	-1.57%
Basic Earnings Per Share	-$0.02	-$0.05
Diluted Earnings Per Share	-$0.02	-$0.05	-$14.07K
COMMON SHARES
Basic Shares Outstanding	19.92M	19.58M
Diluted Shares Outstanding	19.92M	19.58M

Balance Sheet

Concept	2020 Q1	2019 Q1	2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$305.0K	$1.900M	$4.318M
YoY Change	-83.95%	26.67%	23.37%
Cash & Equivalents	$305.0K	$1.900M	$4.318M
Short-Term Investments
Other Short-Term Assets	$2.002M	$1.470M	$1.372M
YoY Change	36.19%	31.96%	19.3%
Inventory	$4.232M	$2.553M	$2.254M
Prepaid Expenses
Receivables	$13.99M	$10.48M	$9.593M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$20.52M	$16.40M	$17.54M
YoY Change	25.16%	3.82%	-0.74%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.382M	$1.368M	$1.445M
YoY Change	220.32%	-11.51%	-11.51%
Goodwill
YoY Change
Intangibles	$14.39M	$18.74M	$19.87M
YoY Change	-23.22%	-19.66%	-18.96%
Long-Term Investments
YoY Change
Other Assets	$158.0K	$149.0K	$137.0K
YoY Change	6.04%	9.56%	4.58%
Total Long-Term Assets	$62.15M	$50.85M	$46.54M
YoY Change	22.24%	3.41%	-9.13%
TOTAL ASSETS
Total Short-Term Assets	$20.52M	$16.40M	$17.54M
Total Long-Term Assets	$62.15M	$50.85M	$46.54M
Total Assets	$82.68M	$67.25M	$64.07M
YoY Change	22.95%	3.51%	-6.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.80M	$9.672M	$7.091M
YoY Change	32.29%	74.43%	28.55%
Accrued Expenses		$1.479M	$0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$7.295M	$5.337M	$4.903M
YoY Change	36.69%	75.62%	61.34%
Total Short-Term Liabilities	$23.80M	$18.48M	$14.79M
YoY Change	28.81%	69.37%	18.57%
LONG-TERM LIABILITIES
Long-Term Debt	$32.33M	$27.52M	$28.84M
YoY Change	17.46%	21.13%	13.77%
Other Long-Term Liabilities	$4.422M	$1.479M
YoY Change	198.99%	7295.0%
Total Long-Term Liabilities	$32.33M	$47.50M	$43.63M
YoY Change	-31.95%	40.82%	15.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$23.80M	$18.48M	$14.79M
Total Long-Term Liabilities	$32.33M	$47.50M	$43.63M
Total Liabilities	$60.66M	$65.98M	$43.63M
YoY Change	-8.06%	47.79%	15.04%
SHAREHOLDERS EQUITY
Retained Earnings	-$61.79M	-$63.69M	-$62.73M
YoY Change	-2.99%	3.68%	1.78%
Common Stock	$2.000K	$2.000K	$2.000K
YoY Change	0.0%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$22.02M	$19.74M	$20.44M
YoY Change
Total Liabilities & Shareholders Equity	$82.68M	$67.25M	$64.07M
YoY Change	22.95%	3.51%	-6.98%

Cashflow Statement

Concept	2020 Q1	2019 Q1	2018 Q4
OPERATING ACTIVITIES
Net Income	-$418.0K	-$960.0K	-$275.0K
YoY Change	-56.46%	-570.59%	-98.47%
Depreciation, Depletion And Amortization	$2.328M	$1.225M	$1.237M
YoY Change	90.04%	-5.04%	-16.42%
Cash From Operating Activities	$557.0K	$1.269M	$3.181M
YoY Change	-56.11%	20.51%	-12.13%
INVESTING ACTIVITIES
Capital Expenditures	$529.0K	-$3.535M	-$3.782M
YoY Change	-114.96%	215.63%	3051.67%
Acquisitions
YoY Change
Other Investing Activities	$500.0K	$764.0K	$975.0K
YoY Change	-34.55%	-20.42%	178.57%
Cash From Investing Activities	-$4.036M	-$2.771M	-$2.807M
YoY Change	45.65%	1579.39%	-1320.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$250.0K	$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$1.137M	-916.0K	62.00K
YoY Change	-224.13%	-67.6%	-105.25%
NET CHANGE
Cash From Operating Activities	$557.0K	1.269M	3.181M
Cash From Investing Activities	-$4.036M	-2.771M	-2.807M
Cash From Financing Activities	$1.137M	-916.0K	62.00K
Net Change In Cash	-$2.342M	-2.418M	436.0K
YoY Change	-3.14%	24.7%	-83.67%
FREE CASH FLOW
Cash From Operating Activities	$557.0K	$1.269M	$3.181M
Capital Expenditures	$529.0K	-$3.535M	-$3.782M
Free Cash Flow	$28.00K	$4.804M	$6.963M
YoY Change	-99.42%	121.08%	86.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001337013
CY2020Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2020Q1	dei	Trading Symbol TradingSymbol	infu
CY2020Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2020Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q1	dei	Entity Registrant Name EntityRegistrantName	InfuSystem Holdings, Inc
CY2019Q4	infu	Medical Equipment In Rental Services Gross MedicalEquipmentInRentalServicesGross	75853000
CY2020Q1	infu	Medical Equipment In Rental Services Reserve MedicalEquipmentInRentalServicesReserve	746000
CY2019Q4	infu	Medical Equipment In Rental Services Reserve MedicalEquipmentInRentalServicesReserve	720000
CY2020Q1	infu	Medical Equipment Net MedicalEquipmentNet	37846000
CY2019Q4	infu	Medical Equipment Held For Sale Or Rental Reserve MedicalEquipmentHeldForSaleOrRentalReserve	28000
CY2020Q1	infu	Medical Equipment In Rental Service Net Of Accumulated Depreciation MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation	34806000
CY2019Q4	infu	Medical Equipment In Rental Service Net Of Accumulated Depreciation MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation	33225000
CY2020Q1	infu	Medical Equipment In Rental Services Accumulated Depreciation MedicalEquipmentInRentalServicesAccumulatedDepreciation	43548000
CY2019Q4	infu	Medical Equipment In Rental Services Accumulated Depreciation MedicalEquipmentInRentalServicesAccumulatedDepreciation	41908000
CY2020Q1	infu	Medical Equipment In Rental Services Gross MedicalEquipmentInRentalServicesGross	79100000
CY2020Q1	infu	Depreciation Expense Related To Medical Equipment DepreciationExpenseRelatedToMedicalEquipment	2100000
CY2019Q1	infu	Depreciation Expense Related To Medical Equipment DepreciationExpenseRelatedToMedicalEquipment	1700000
CY2020Q1	infu	Longterm Debt Maturities Repayments Of Principal In Year Five And Thereafter LongtermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter	12156000
CY2020Q1	infu	Medical Equipment Held For Sale Or Rental MedicalEquipmentHeldForSaleOrRental	3040000
CY2019Q4	infu	Medical Equipment Held For Sale Or Rental MedicalEquipmentHeldForSaleOrRental	1306000
CY2020Q1	infu	Medical Equipment Held For Sale Or Rental Gross MedicalEquipmentHeldForSaleOrRentalGross	3068000
CY2019Q4	infu	Medical Equipment Held For Sale Or Rental Gross MedicalEquipmentHeldForSaleOrRentalGross	1334000
CY2020Q1	infu	Medical Equipment Held For Sale Or Rental Reserve MedicalEquipmentHeldForSaleOrRentalReserve	28000
CY2019Q4	infu	Medical Equipment Net MedicalEquipmentNet	34531000
CY2020Q1	infu	Payments To Acquire Medical Equipment PaymentsToAcquireMedicalEquipment	4007000
CY2019Q1	infu	Payments To Acquire Medical Equipment PaymentsToAcquireMedicalEquipment	3495000
CY2020Q1	infu	Revenues External RevenuesExternal	21553000
CY2019Q1	infu	Revenues External RevenuesExternal	18193000
CY2020Q1	infu	Revenues Internal RevenuesInternal
CY2019Q1	infu	Revenues Internal RevenuesInternal
CY2020Q1	infu	Unamortized Debt Issuance Expense Current UnamortizedDebtIssuanceExpenseCurrent	17000
CY2019Q4	infu	Unamortized Debt Issuance Expense Current UnamortizedDebtIssuanceExpenseCurrent	17000
CY2020Q1	infu	Unamortized Debt Issuance Expense Noncurrent UnamortizedDebtIssuanceExpenseNoncurrent	62000
CY2019Q4	infu	Unamortized Debt Issuance Expense Noncurrent UnamortizedDebtIssuanceExpenseNoncurrent	66000
CY2020Q1	infu	Unamortized Value Of Debt Issuance Costs Principal Current UnamortizedValueOfDebtIssuanceCostsPrincipalCurrent	13000
CY2020Q1	infu	Unamortized Value Of Debt Issuance Costs Principal In Year Five And Thereafter UnamortizedValueOfDebtIssuanceCostsPrincipalInYearFiveAndThereafter	15000
CY2020Q1	infu	Unamortized Value Of Debt Issuance Costs Principal In Year Four UnamortizedValueOfDebtIssuanceCostsPrincipalInYearFour	17000
CY2020Q1	infu	Unamortized Value Of Debt Issuance Costs Principal In Year Three UnamortizedValueOfDebtIssuanceCostsPrincipalInYearThree	17000
CY2020Q1	infu	Unamortized Value Of Debt Issuance Costs Principal In Year Two UnamortizedValueOfDebtIssuanceCostsPrincipalInYearTwo	17000
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	12795000
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7962000
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13985000
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	12097000
CY2020Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2843000
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2648000
CY2020Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	83803000
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	83699000
CY2019Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	37000
CY2020Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	426000
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	53000
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	74000
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	246000
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	206000
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1075000
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1125000
CY2020Q1	us-gaap	Assets Assets	82678000
CY2019Q1	us-gaap	Assets Assets	67245000
CY2019Q4	us-gaap	Assets Assets	79224000
CY2020Q1	us-gaap	Assets Current AssetsCurrent	20524000
CY2019Q4	us-gaap	Assets Current AssetsCurrent	19305000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2647000
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4318000
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	305000
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1900000
CY2020Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2342000
CY2019Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2418000
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23543414
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23400625
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20024925
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19882136
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	2000
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	2000
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8890000
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7852000
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	548000
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2051000
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3930000
CY2020Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12388000
CY2020Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	113000
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	104000
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3402000
CY2019Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2905000
CY2020Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	200000
CY2019Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	100000
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.05
CY2020Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	35399000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	34324000
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	2101000
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	3210000
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	548000
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8652000
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7132000
CY2020Q1	us-gaap	Gross Profit GrossProfit	12663000
CY2019Q1	us-gaap	Gross Profit GrossProfit	10341000
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-389000
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-901000
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29000
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	59000
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2019Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2020Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	49787000
CY2019Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	49787000
CY2020Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	14388000
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	15463000
CY2020Q1	us-gaap	Interest Expense InterestExpense	403000
CY2019Q1	us-gaap	Interest Expense InterestExpense	460000
CY2020Q1	us-gaap	Inventory Net InventoryNet	4232000
CY2019Q4	us-gaap	Inventory Net InventoryNet	2899000
CY2020Q1	us-gaap	Lease Cost LeaseCost	536000
CY2019Q1	us-gaap	Lease Cost LeaseCost	462000
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	8177000
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	3166000
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	947000
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	924000
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	991000
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1055000
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1094000
CY2020Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2460000
CY2020Q1	us-gaap	Liabilities Liabilities	60658000
CY2019Q4	us-gaap	Liabilities Liabilities	56890000
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	82678000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	79224000
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	23798000
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	21847000
CY2020Q1	us-gaap	Long Term Debt LongTermDebt	39620000
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	38377000
CY2020Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	7295000
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	8082000
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	7053000
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	7275000
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	7778000
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	5358000
CY2020Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	32325000
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	30295000
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1137000
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-916000
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4036000
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2771000
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	557000
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1269000
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-960000
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-418000
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2020Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	12630000
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	10761000
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	33000
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-420000
CY2020Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	424000
CY2019Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	387000
CY2020Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	5717000
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4422000
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4644000
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	451000
CY2019Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	360000
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5380000
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5733000
CY2020Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.077
CY2019Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.066
CY2020Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y109D
CY2019Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y
CY2020Q1	us-gaap	Other Assets Current OtherAssetsCurrent	2002000
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1662000
CY2020Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	158000
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	155000
CY2020Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3708000
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5803000
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-19000
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-21000
CY2020Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts
CY2019Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3000
CY2020Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	426000
CY2019Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	37000
CY2020Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	4536000
CY2019Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	3535000
CY2020Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2020Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q1	us-gaap	Preferred Stock Value PreferredStockValue
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	250000
CY2019Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
CY2020Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	10468000
CY2019Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities
CY2020Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	500000
CY2019Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	764000
CY2020Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	74000
CY2019Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	53000
CY2020Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7225000
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6685000
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4382000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4037000
CY2020Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	285000
CY2019Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-98000
CY2020Q1	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	9229000
CY2019Q1	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	929000
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-61785000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-61367000
CY2020Q1	us-gaap	Revenues Revenues	21553000
CY2019Q1	us-gaap	Revenues Revenues	18193000
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	118000
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	112000
CY2020Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2618000
CY2019Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2602000
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	250000
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	20441000
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	19743000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	22334000
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	22020000
CY2020Q1	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	79000
CY2019Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	83000
CY2020Q1	us-gaap	Variable Lease Cost VariableLeaseCost	112000
CY2019Q1	us-gaap	Variable Lease Cost VariableLeaseCost	75000
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19918298
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19580049
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19918298
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19580049
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19918298
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19580049

Files In Submission

Name	View Source	Status
0001437749-20-010921-index-headers.html	Edgar Link	pending
0001437749-20-010921-index.html	Edgar Link	pending
0001437749-20-010921.txt	Edgar Link	pending
0001437749-20-010921-xbrl.zip	Edgar Link	pending
ex_185747.htm	Edgar Link	pending
ex_185748.htm	Edgar Link	pending
ex_185749.htm	Edgar Link	pending
ex_185750.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
infu-20200331.xml	Edgar Link	completed
infu-20200331.xsd	Edgar Link	pending
infu-20200331_cal.xml	Edgar Link	unprocessable
infu-20200331_def.xml	Edgar Link	unprocessable
infu-20200331_lab.xml	Edgar Link	unprocessable
infu-20200331_pre.xml	Edgar Link	unprocessable
infu20200331_10q.htm	Edgar Link	pending
infu20200331_10qimg001.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INFU
InfuSystem Holdings, Inc Stock $infu

2020 Q1 Form 10-Q Financial Statement

#000143774920010921 Filed on May 15, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INFU InfuSystem Holdings, Inc Stock $infu

2020 Q1 Form 10-Q Financial Statement

#000143774920010921 Filed on May 15, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INFU
InfuSystem Holdings, Inc Stock $infu